This NIH grant funds collaborative international research projects with at least one foreign subproject, supporting innovative global partnerships that advance the missions of participating NIH Institutes.
Funder: National Institutes of Health
Due Dates: January 7, 2027 (AIDS-related) | January 25, 2027 (General) | May 7, 2027 (AIDS-related) | May 25, 2027 (General) | September 7, 2027 (AIDS-related) | September 25, 2027 (General) | January 7, 2028 (AIDS-related) | January 25, 2028 (General) | May 7, 2028 (AIDS-related) | May 25, 2028 (General) | September 7, 2028 (AIDS-related) | September 25, 2028 (General) | January 7, 2029 (AIDS-related) | January 25, 2029 (General) | May 7, 2029 (AIDS-related)
Funding Amounts: No budget cap; generally up to 5 years without clinical trials or 7 years with clinical trials
Summary: Supports NIH-mission research collaborations between U.S.-based prime organizations and foreign organizations through linked domestic and international awards.
Key Information: A domestic prime applicant and at least one funded International Project are required; foreign organizations cannot apply as prime applicants.
NIH’s Parent PF5 mechanism supports funded international research collaborations in scientific areas aligned with participating NIH Institutes, Centers, and Offices. It establishes a domestic prime award linked to independent foreign awards, enabling NIH oversight and tracking of international funding. Applications may propose clinical trials or research without clinical trials.
The program emphasizes collaborations that bring unusual talent, resources, populations, or environmental conditions unavailable in the United States or that augment U.S. resources. Each application combines an overall collaborative plan, domestic research, and international project work. International contributions should be essential to the research and have the potential to advance health sciences in the United States. This mechanism is not intended for projects whose only international elements are consultants, foreign purchases, or collaborations without NIH funding.